Sapheon has filed with the FDA the first module of its premarket approval application for VenaSeal Sapheon, a device used for treating varicose veins. The system, which already has CE mark approval in Europe, is undergoing an investigational device exemption trial in the U.S.
Sapheon seeks FDA approval for device to treat varicose veins
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan